![]() |
Volumn 345, Issue 23, 2001, Pages 1667-1675
|
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
CARVEDILOL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
INOTROPIC AGENT;
LISINOPRIL;
METOPROLOL;
PLACEBO;
QUINAPRIL;
RAMIPRIL;
VALSARTAN;
VASODILATOR AGENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART ARREST;
HEART EJECTION FRACTION;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
HYPOTENSION;
INTRAVENOUS ADMINISTRATION;
KIDNEY DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MORTALITY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
VERTIGO;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
MALE;
MIDDLE AGED;
PROBABILITY;
QUALITY OF LIFE;
RECEPTORS, ANGIOTENSIN;
STROKE VOLUME;
SURVIVAL ANALYSIS;
TETRAZOLES;
VALINE;
|
EID: 0035818884
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa010713 Document Type: Article |
Times cited : (2892)
|
References (30)
|